Exact Mass: 308.0201

Exact Mass Matches: 308.0201

Found 37 metabolites which its exact mass value is equals to given mass value 308.0201, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

   

ascidiathiazone A

ascidiathiazone A

C12H8N2O6S (308.0103)


An organic heterotricyclic compound, that is 3,4-dihydro-2H-[1,4]thiazino[2,3-g]quinoline-5,10 dione S,S-dioxide substituted at position 7 by a carboxyl group. It is an anti-inflmmatory alkaloid obtained from Aplidium.

   

1,1,1-TRICHLORO-4-HYDROXY-11-METHYLDODECA-3,5,7,9-TETRAEN-2-ONE

1,1,1-TRICHLORO-4-HYDROXY-11-METHYLDODECA-3,5,7,9-TETRAEN-2-ONE

C13H15Cl3O2 (308.0138)


   
   

Bis(3-nitrophenyl)sulfone

Bis(3-nitrophenyl)sulfone

C12H8N2O6S (308.0103)


   

ETHYL 5-BROMO-1-(4-METHYLPHENYL)-1H-PYRAZOLE-4-CARBOXYLATE

ETHYL 5-BROMO-1-(4-METHYLPHENYL)-1H-PYRAZOLE-4-CARBOXYLATE

C13H13BrN2O2 (308.016)


   

Propanimidic acid,3,3-dithiobis-, 1,1-dimethyl ester, hydrochloride (1:2)

Propanimidic acid,3,3-dithiobis-, 1,1-dimethyl ester, hydrochloride (1:2)

C8H18Cl2N2O2S2 (308.0187)


   

2-bromo-1,1:4,1-terphenyl

2-bromo-1,1:4,1-terphenyl

C18H13Br (308.0201)


   

ethyl 3-(4-bromophenyl)-1-methyl-1h-pyrazole-5-carboxylate

ethyl 3-(4-bromophenyl)-1-methyl-1h-pyrazole-5-carboxylate

C13H13BrN2O2 (308.016)


   

5-(4-bromophenyl)-1-(tetrahydro-2H-pyran-2-yl)tetrazole

5-(4-bromophenyl)-1-(tetrahydro-2H-pyran-2-yl)tetrazole

C12H13BrN4O (308.0273)


   

1,1:2,1-Terphenyl,2-bromo- (9CI)

1,1:2,1-Terphenyl,2-bromo- (9CI)

C18H13Br (308.0201)


   

ETHYL 4-(4-CHLOROPHENYL)-5-CYANAMIDE-4,5-DIHYDRO-1,3,4-THIADIAZOLE-2-CARBOXYLATE

ETHYL 4-(4-CHLOROPHENYL)-5-CYANAMIDE-4,5-DIHYDRO-1,3,4-THIADIAZOLE-2-CARBOXYLATE

C12H9ClN4O2S (308.0135)


   

1-Bromo-3,5-diphenylbenzene

1-Bromo-3,5-diphenylbenzene

C18H13Br (308.0201)


   

Benzene,1,1-[(1E)-1,2-ethenediylbis(sulfonyl)]bis-

Benzene,1,1-[(1E)-1,2-ethenediylbis(sulfonyl)]bis-

C14H12O4S2 (308.0177)


   

1-bromo-2,4-diphenylbenzene

1-bromo-2,4-diphenylbenzene

C18H13Br (308.0201)


   

4,4-Difluoro-3,3-dinitrobenzophenone

4,4-Difluoro-3,3-dinitrobenzophenone

C13H6F2N2O5 (308.0245)


   

4-amino-8-bromo-N-propylcinnoline-3-carboxamide

4-amino-8-bromo-N-propylcinnoline-3-carboxamide

C12H13BrN4O (308.0273)


   

6-amino-3-(2,6-dichlorophenyl)-1-methylpyrazolo[1,5-a]pyrimidin-2-one

6-amino-3-(2,6-dichlorophenyl)-1-methylpyrazolo[1,5-a]pyrimidin-2-one

C13H10Cl2N4O (308.0232)


   

cis-1,2-Bis(phenylsulfonyl)ethylene

cis-1,2-Bis(phenylsulfonyl)ethylene

C14H12O4S2 (308.0177)


   

Tris(2,2,2-trifluoroethyl) borate

Tris(2,2,2-trifluoroethyl) borate

C6H6BF9O3 (308.0266)


   

PalladiuM pivalate

PalladiuM pivalate

C10H18O4Pd (308.024)


   

Bis(4-nitrophenyl) Sulfone

Bis(4-nitrophenyl) Sulfone

C12H8N2O6S (308.0103)


   

2-Chlorobenzoic acid 2-(4-chlorobenzoyl)hydrazide

2-Chlorobenzoic acid 2-(4-chlorobenzoyl)hydrazide

C14H10Cl2N2O2 (308.0119)


   

3-[(4-Bromo-3,5-dimethyl-1H-pyrazol-1-yl)methyl]-benzoic acid

3-[(4-Bromo-3,5-dimethyl-1H-pyrazol-1-yl)methyl]-benzoic acid

C13H13BrN2O2 (308.016)


   

1,1-bis(phenylsulfonyl)ethylene

1,1-bis(phenylsulfonyl)ethylene

C14H12O4S2 (308.0177)


   

5-[3,5-BIS(TRIFLUOROMETHYL)PHENYL]-2-FURALDEHYDE

5-[3,5-BIS(TRIFLUOROMETHYL)PHENYL]-2-FURALDEHYDE

C13H6F6O2 (308.0272)


   

4-Bromo-p-terphenyl

4-Bromo-p-terphenyl

C18H13Br (308.0201)


   

N-[4-(Aminosulfonyl)phenyl]-2-Mercaptobenzamide

N-[4-(Aminosulfonyl)phenyl]-2-Mercaptobenzamide

C13H12N2O3S2 (308.0289)


   

S-(4-chlorophenyl) 3,4-dimethoxybenzenecarbothioate

S-(4-chlorophenyl) 3,4-dimethoxybenzenecarbothioate

C15H13ClO3S (308.0274)


   

5-(4-bromophenyl)-N-propan-2-yl-3-isoxazolecarboxamide

5-(4-bromophenyl)-N-propan-2-yl-3-isoxazolecarboxamide

C13H13BrN2O2 (308.016)


   

IC87201

IC87201

C13H10Cl2N4O (308.0232)


IC87201, an inhibitor of PSD95-nNOS protein-protein interactions, suppresses NMDAR-dependent NO and cGMP formation.

   

TC-S 7009

TC-S 7009

C12H6ClFN4O3 (308.0112)


TC-S 7009 is a potent and selective HIF-2α inhibitor with a Kd of 81 nM. TC-S 7009 is more selective for HIF-2α than HIF-1α (Kd ? 5 μM). TC-S 7009 disrupts HIF-2α heterodimerization, decreases DNA-binding activity, and reduces HIF-2α target gene expression[1][2].

   

4,4,5,10-tetraoxo-1h,2h,3h-4λ⁶-[1,4]thiazino[3,2-g]quinoline-7-carboxylic acid

4,4,5,10-tetraoxo-1h,2h,3h-4λ⁶-[1,4]thiazino[3,2-g]quinoline-7-carboxylic acid

C12H8N2O6S (308.0103)


   

5-chloro-2-[3-(dichloromethylidene)hexyl]benzene-1,3-diol

5-chloro-2-[3-(dichloromethylidene)hexyl]benzene-1,3-diol

C13H15Cl3O2 (308.0138)


   

(1r,11r)-11-(hydroxymethyl)-15-methyl-12,13-dithia-9,15-diazatetracyclo[9.2.2.0¹,⁹.0³,⁸]pentadeca-3,5,7-triene-10,14-dione

(1r,11r)-11-(hydroxymethyl)-15-methyl-12,13-dithia-9,15-diazatetracyclo[9.2.2.0¹,⁹.0³,⁸]pentadeca-3,5,7-triene-10,14-dione

C13H12N2O3S2 (308.0289)


   

(3z,5e,7e,9e)-1,1,1-trichloro-4-hydroxy-11-methyldodeca-3,5,7,9-tetraen-2-one

(3z,5e,7e,9e)-1,1,1-trichloro-4-hydroxy-11-methyldodeca-3,5,7,9-tetraen-2-one

C13H15Cl3O2 (308.0138)


   

11-(hydroxymethyl)-15-methyl-12,13-dithia-9,15-diazatetracyclo[9.2.2.0¹,⁹.0³,⁸]pentadeca-3,5,7-triene-10,14-dione

11-(hydroxymethyl)-15-methyl-12,13-dithia-9,15-diazatetracyclo[9.2.2.0¹,⁹.0³,⁸]pentadeca-3,5,7-triene-10,14-dione

C13H12N2O3S2 (308.0289)